Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine SGB for Pediatric Autism
NCT06301685Not yet recruiting
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of lidocaine in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoint: Childhood Autism Rating Scale at day 10. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT06301685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301685.